|
|
Hamlet Hayrapetyan, MD, PhD, - Effects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomized double – blind Placebo- controlled international multicenter study. Study assessing the morbi - mortality benefits of the If inhibitor Ivad
|
|
|
Гамлет Айрапетян, - Effects of Ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind Placebo-controlled international multicentre study. Study assessing the morbi-mortality benefits of the If inhibitor Ivabradine
|
|
|
Համլետ Հայրապետյան, - Effects of Ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind Placebo-controlled international multicentre study. Study assessing the morbi-mortality benefits of the If inhibitor Ivabradine
|
